CHEMIEWERK HOMBURG ZWEIGNIEDERLASSUNG DER DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER – Trademark Portfolio

Entity Type: 98

CHEMIEWERK HOMBURG ZWEIGNIEDERLASSUNG DER DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category.

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ILDAMEN
ILDAMEN
Cancelled 1966

Trademark Classifications

CHEMIEWERK HOMBURG ZWEIGNIEDERLASSUNG DER DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CHEMIEWERK HOMBURG ZWEIGNIEDERLASSUNG DER DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER have?

CHEMIEWERK HOMBURG ZWEIGNIEDERLASSUNG DER DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER has 1 U.S. trademark filed with the USPTO.

What trademark classes does CHEMIEWERK HOMBURG ZWEIGNIEDERLASSUNG DER DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER file in?

CHEMIEWERK HOMBURG ZWEIGNIEDERLASSUNG DER DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is CHEMIEWERK HOMBURG ZWEIGNIEDERLASSUNG DER DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER's trademark registration success rate?

CHEMIEWERK HOMBURG ZWEIGNIEDERLASSUNG DER DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.